Hbv Sentence Examples

The agent from which transfusion recipients during 2003-2004 were most at risk was HBV.

Hepatitis B is a liver disease caused by the hepatitis B virus (HBV).

Transmission of HBV occurs through blood and body fluid exposure such as blood, semen, vaginal secretions, or saliva.

According to the Centers for Disease Control (CDC), an estimated 78,000 persons in the United States were infected with HBV in 2001.

People of all ages get hepatitis B, and about 5,000 die per year of sickness caused by HBV.

Hepatitis B is caused by HBV, also called Hepadna virus.

Medications. There is no medicine that gets rid of HBV or heals the liver.

If mothers have HBV in their blood, they can give hepatitis B to their baby during childbirth.

Babies who get HBV at birth may have the virus for the rest of their lives, can spread the disease, and can get cirrhosis of the liver or liver cancer.

The CDC recommends that all pregnant women be tested for HBV early in their pregnancy.

Hepatitis B virus (HBV)-Also called Hepadna virus, the pathogen responsible for hepatitis B infection.

It the mother of a newborn carries the hepatitis B virus (HBV) in her blood, the baby needs to receive the first shot within 12 hours of birth.

If the mother shows no evidence of HBV in her blood, the first dose may be deferred to the two-month exam.

The hepatitis B vaccine (HBV or HepB) is an injection that protects children from contracting hepatitis B, a serious disease caused by the hepatitis B virus.

After vaccination with HBV, the child's immune system recognizes HBsAg as foreign and produces antibodies that attach to the protein (anti-HBs).

The second and third HBV immunizations are administered by the age of 18 months, in conjunction with other routine childhood vaccinations.

An HBV derived from the blood serum of people with hepatitis B was as of 2004 no longer produced in the United States.

Therefore, the HBV dose should be determined by a medical professional.

Although the vast majority of parents believe that vaccinations are important for their children, the majority of parents are also concerned about the safety of vaccines including HBV.

Although controversy over the safety of HBV resulted in congressional hearings in 1999, the National Academy of Science's Institute of Medicine, as well as other authorities, considers HBV to be safe.

Repeated studies have found no association between HBV and sudden infant death syndrome (SIDS) or other medical conditions, including neurological or immune system disorders.

Although the majority of these children responded positively to a booster HBV immunization, one-third of them did not respond.

The U.S. Centers for Disease Control and Prevention (CDC) estimates that, prior to the launch of the infant HBV immunization program, about 33,000 American children of non-infected mothers acquired hepatitis B by the age of ten.

The CDC estimates that, prior to the infant HBV immunization program, about 12,000 American infants per year were infected by their mothers at birth.

Children born to mothers who have hepatitis B or whose hepatitis B status is unknown should receive their first HBV dose within 12 hours of birth.

It is recommended that newborns whose mothers are HBsAg-positive receive hepatitis B immune globulin (HBIG)-a preparation of serum containing high levels of antibodies to hepatitis B-as well as HBV within 12 hours of birth.

A child's immune response to either hepatitis B infection or to HBV can be measured by a blood test for antibodies to HBsAg (anti-HBs).

If a vaccinated child is exposed to hepatitis B, a measure of the anti-HBs in the blood will indicate whether another dose of HBV is required.

However, as of 2004, infants receiving HBV since 1991 had not yet reached the age when high-risk behaviors increase the likelihood of hepatitis B infection.

The CDC estimates that infant hepatitis B vaccination saves fifty cents in direct medical costs for every dollar spent on HBV.

Children should not receive HBV if they are allergic to baker's yeast or thimerosal, are allergic to any other components in a combination vaccine, or have had a previous allergic reaction to HBV.

A 2003 study found that HBV was safe and effective in children with asthma, even those on inhaled steroid therapy.

Although allergic reactions to HBV are rare, if they occur emergency medical help should be sought immediately.

Hepatitis B immune globulin-HBIG, a blood serum preparation containing anti-hepatitis-B antibodies (anti-HBs) that is administered along with HBV to children born to hepatitis-B-infected mothers.